Tag: TLAB

Blue Horseshoe Stocks: Options Trading Ideas

Apple, Inc. AAPL – Options
–
On Wednesday we honed in on Apple’s big news, the addition of Burberry CEO Angela Ahrendts as its new chief of retail, and mentioned that we were monitoring the 11/01 $505 and $510 Calls. At the time those contracts were trading in the low $12’s, and $10’s respectively.

We were still watching on Friday, and were duly rewarded for our patience; the $505 Calls jumped nearly 50% from the lows in the $12-range to a high of 17.10. As for the $510’s, they went on to close at 14.50, a 45% increase from the low of $10.

This morning, AAPL is gapping up to the tune of more than 0.5%, which means these Calls should be pushed even deeper into the money. That would provide us with significant added gains.

Facebook, Inc. FB – Options

Much like AAPL, FB has become one of our favorite target vehicles for trading options contracts. If you recall, we successfully pursued over 750% in cumulative gains out of FB Calls the Friday before last, and in sticking with the same strategy last week as we pointed out on Friday, similar opportunities were presented in the Calls once again.

Extended Watchlist:
VPLM, TLAB, NTS, EWRL, ETEK, INVA, ENMD(coming off of recent lows)

GALE, EDWY & Extended Watchlist

 

Galena Biopharma, Inc. GALE

We were happy to see that GALE earned us a spot on Penny Stock Rumble’s Top Gainers List this week. From its low (Wed.) of 1.6525 to yesterday’s high of 2.10, we saw total possible gains of 27% The stock had news out, and closed strong on the day at 2.04 on around 3X the average volume.

The GALE Chart is exhibiting all the telltale signs of a momentum mover, and we’re glad we were watching closely enough to hitch a ride! As you can see below, the RSI is screaming toward the power zone, while the Slow STO and the PPO have just crossed and are swinging sharply to the North.

Yesterday’s News:

LAKE OSWEGO, Ore., Nov 29, 2012 (GlobeNewswire via COMTEX) — Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced two presentations at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium. The event will be held December 4-8, 2012 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.

____

eDoorways International Corp. EDWY

EDWY first appeared on our extended watchlist this week. The stock recently ran from a low of .005 to a high of a nickel (+810%) between Sept 18 and Nov 1st. Following that big run, the stock consolidated to find support off of a penny-and-a-half.

Yesterday we observed trades as low as .0153, and as high as .025, for total possible gains of over 60% on the day. We are looking at key levels of resistance at .026 (20DMA) and .031 (200DMA), and judging by the history of the stock, a push past those levels could really lead to a serious breakout.

Indicators on the chart all seem to be shaping up rather nicely. We notice that the Accum/Dist has been steadily rising, the RSI is just on the cusp of breaking the 50DMA, and the PPO is currently pinching, hinting at a bullish cross. The bars on the histogram are also about to flip up to the bullish side, and we had a recent cross on the Slow STO.

____

Extended Watchlist:
TLAB, UTSI, PPHM, MAXD, SRGE, HLNT,